多疗程DC-CIK免疫疗法治疗晚期肺癌的临床疗效(4)
[13]Qin W，Xiong Y，Chen J，et al.DC-CIK cells derived from ovarian cancer patient menstrual blood activate the TNFR1-ASK1-AIP1 pathway to kill autologous ovarian cancer stem cells[J].Cell Mol Med，2018，22(7)：3364-3376.
[14]Hu J，Hu J，Liu X，et al.Effect and safety of cytokine-induced killer (CIK) cell immunotherapy in patients with breast cancer[J]. Medicine，2017，96(42)：e8310.
[15]Xiao X，Ye X，Xu C，et al.Successful alternative treatment for relapsed adult acute lymphoblastic leukemia with dendritic cells-cytokine-induced killer cells combined with a rituximab-based regimen[J].Onco Targets Ther，2018，29(11)：7555-7558.
[16]Dhupkar P，Gordon N.Interleukin-2：Old and New Approaches to Enhance Immune-Therapeutic Efficacy[J].Adv Exp Med Biol，2017(995)：33-51.
[17]Gong W，Hoffmann JM，Stock S，et al.Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells[J].Cancer Immunol Immunother，2019，68(7)：1195-1209.
[18]Wang L，Wang Y，Song Z，et al.Interferon Cytokine Res[J]. Deficiency of interferon-gamma or its receptor promotes colorectal cancer development，2015，35(4)：273-280.
收稿日期：2019-7-2;修回日期：2019-7-13
編辑/肖婷婷, 百拇医药(周立莉 周冬霞 徐寿华 吴金芸 蔡茂怀)
[14]Hu J，Hu J，Liu X，et al.Effect and safety of cytokine-induced killer (CIK) cell immunotherapy in patients with breast cancer[J]. Medicine，2017，96(42)：e8310.
[15]Xiao X，Ye X，Xu C，et al.Successful alternative treatment for relapsed adult acute lymphoblastic leukemia with dendritic cells-cytokine-induced killer cells combined with a rituximab-based regimen[J].Onco Targets Ther，2018，29(11)：7555-7558.
[16]Dhupkar P，Gordon N.Interleukin-2：Old and New Approaches to Enhance Immune-Therapeutic Efficacy[J].Adv Exp Med Biol，2017(995)：33-51.
[17]Gong W，Hoffmann JM，Stock S，et al.Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells[J].Cancer Immunol Immunother，2019，68(7)：1195-1209.
[18]Wang L，Wang Y，Song Z，et al.Interferon Cytokine Res[J]. Deficiency of interferon-gamma or its receptor promotes colorectal cancer development，2015，35(4)：273-280.
收稿日期：2019-7-2;修回日期：2019-7-13
編辑/肖婷婷, 百拇医药(周立莉 周冬霞 徐寿华 吴金芸 蔡茂怀)